These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 6684202

  • 21. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [Abstract] [Full Text] [Related]

  • 22. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.
    Steinpreis RE, Salamone JD.
    Brain Res; 1993 May 28; 612(1-2):263-70. PubMed ID: 8330204
    [Abstract] [Full Text] [Related]

  • 23. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T, Zetterström T, Ljungberg T, Ungerstedt U.
    Brain Res; 1987 Jan 20; 401(2):322-30. PubMed ID: 3815099
    [Abstract] [Full Text] [Related]

  • 24. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 20; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 25. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov 20; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 26. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine.
    Johnson KM.
    Fed Proc; 1983 Jun 20; 42(9):2579-83. PubMed ID: 6133782
    [Abstract] [Full Text] [Related]

  • 27. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
    Lipska BK, Weinberger DR.
    Neuropsychopharmacology; 1994 May 20; 10(3):199-205. PubMed ID: 7916917
    [Abstract] [Full Text] [Related]

  • 28. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release.
    Peris J, Decambre N, Coleman-Hardee ML, Simpkins JW.
    Brain Res; 1991 Dec 06; 566(1-2):255-64. PubMed ID: 1814541
    [Abstract] [Full Text] [Related]

  • 29. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG, Damsma G, Wenkstern D, Fibiger HC.
    Eur J Pharmacol; 1991 Mar 19; 195(1):63-73. PubMed ID: 2065713
    [Abstract] [Full Text] [Related]

  • 30. Alterations in amphetamine-induced locomotor activity and stereotypy after electrical stimulation of the nucleus accumbens and neostriatum.
    Kokkinidis L, Kirkby RD, McCarter BD, Borowski TB.
    Life Sci; 1989 Mar 19; 44(9):633-41. PubMed ID: 2927262
    [Abstract] [Full Text] [Related]

  • 31. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM, Elands J, Király I, Wolterink G.
    Eur J Pharmacol; 1989 Aug 03; 166(3):441-52. PubMed ID: 2572429
    [Abstract] [Full Text] [Related]

  • 32. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E, Friedman E.
    Eur J Pharmacol; 1981 Nov 19; 76(1):25-9. PubMed ID: 7318921
    [Abstract] [Full Text] [Related]

  • 33. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY, Chai BL, Thompson PA, Yamamoto BK.
    J Pharmacol Exp Ther; 1994 Mar 19; 268(3):1452-61. PubMed ID: 8138957
    [Abstract] [Full Text] [Related]

  • 34. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
    Kuczenski R, Schmidt D, Leith N.
    Brain Res; 1977 Apr 22; 126(1):117-29. PubMed ID: 558038
    [Abstract] [Full Text] [Related]

  • 35. A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat.
    Sturgeon RD, Fessler RG, London SF, Meltzer HY.
    Eur J Pharmacol; 1981 Nov 19; 76(1):37-53. PubMed ID: 6119221
    [Abstract] [Full Text] [Related]

  • 36. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis SD, Widerlöv E, Frye GD, Kilts CA, Beaumont K, Breese GR, Prange AJ.
    J Pharmacol Exp Ther; 1983 May 19; 225(2):337-45. PubMed ID: 6682440
    [Abstract] [Full Text] [Related]

  • 37. The neurochemical basis for the behavioral effects of triadimefon.
    Hill D, Ikaiddi M, Mazzio E, Soliman KF.
    Ann N Y Acad Sci; 2000 Sep 19; 914():336-53. PubMed ID: 11085334
    [Abstract] [Full Text] [Related]

  • 38. Modification of behavioral and neurochemical effects of cocaine by haloperidol.
    Bhattacharyya AK, Aulakh CS, Pradhan S, Ghosh P, Pradhan SN.
    Arch Int Pharmacodyn Ther; 1979 Mar 19; 238(1):71-80. PubMed ID: 39530
    [Abstract] [Full Text] [Related]

  • 39. Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
    Swerdlow NR, Lee D, Koob GF, Vaccarino FJ.
    J Pharmacol Exp Ther; 1985 Nov 19; 235(2):324-9. PubMed ID: 3932641
    [Abstract] [Full Text] [Related]

  • 40. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo.
    Blaha CD, Lane RF.
    Neurosci Lett; 1987 Jul 22; 78(2):199-204. PubMed ID: 2888060
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.